| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly and Company | $988.19 | 2.1% | $933.66B | 43.1 | 129% | 0.6% | Healthcare | 20.3% | 47.4% | ||
| 2 | Johnson & Johnson | $225.59 | 0.6% | $543.64B | 39.0 | 78.9% | 2.2% | Healthcare | 45.5% | 3.7% | ||
| 3 | AstraZeneca PLC | $181.24 | -1.2% | $280.97B | 27.7 | 33.1% | 1.8% | Healthcare | 24.2% | 9.9% | ||
| 4 | Bristol-Myers Squibb Company | $56.92 | -0.8% | $116.22B | 16.5 | 33.6% | 4.3% | Healthcare | 13.7% | 1.8% | ||
| 5 | Bristol-Myers Squibb Company Ce | $0.10 | 5.3% | $204M | 0.0 | 33.6% | 100% | Healthcare | 243.6% | 1.8% |